These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 12409738)
1. Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. Walker UA; Setzer B; Venhoff N AIDS; 2002 Nov; 16(16):2165-73. PubMed ID: 12409738 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Venhoff N; Setzer B; Melkaoui K; Walker UA Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion. Campbell GR; Pallack ZT; Spector SA AIDS; 2013 Jun; 27(9):1397-401. PubMed ID: 23435299 [TBL] [Abstract][Full Text] [Related]
4. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors. Reiss P; Casula M; de Ronde A; Weverling GJ; Goudsmit J; Lange JM HIV Med; 2004 Jan; 5(1):11-4. PubMed ID: 14731163 [TBL] [Abstract][Full Text] [Related]
5. Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells. Walker UA; Venhoff N; Koch EC; Olschewski M; Schneider J; Setzer B Antivir Ther; 2003 Oct; 8(5):463-70. PubMed ID: 14640394 [TBL] [Abstract][Full Text] [Related]
6. Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors. Sirivichayakul S; Ruxrungtham K; Ungsedhapand C; Techasathit W; Ubolyam S; Chuenyam T; Emery S; Cooper D; Lange J; Phanuphak P AIDS; 2003 Sep; 17(13):1889-96. PubMed ID: 12960821 [TBL] [Abstract][Full Text] [Related]
7. Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions. Walker UA; Auclair M; Lebrecht D; Kornprobst M; Capeau J; Caron M Antivir Ther; 2006; 11(1):25-34. PubMed ID: 16518957 [TBL] [Abstract][Full Text] [Related]
8. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity. Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687 [TBL] [Abstract][Full Text] [Related]
9. Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes. Setzer B; Schlesier M; Thomas AK; Walker UA Antivir Ther; 2005; 10(2):327-34. PubMed ID: 15865227 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments. Note R; Maisonneuve C; Lettéron P; Peytavin G; Djouadi F; Igoudjil A; Guimont MC; Biour M; Pessayre D; Fromenty B Antimicrob Agents Chemother; 2003 Nov; 47(11):3384-92. PubMed ID: 14576092 [TBL] [Abstract][Full Text] [Related]
11. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes. Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183 [TBL] [Abstract][Full Text] [Related]
12. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy. Moore JD; Acosta EP; Johnson VA; Bassett R; Eron JJ; Fischl MA; Long MC; Kuritzkes DR; Sommadossi JP Antivir Ther; 2007; 12(6):981-6. PubMed ID: 17926654 [TBL] [Abstract][Full Text] [Related]
13. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication. Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982 [TBL] [Abstract][Full Text] [Related]
14. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells. Carter MM; Torres SM; Cook DL; McCash CL; Yu M; Walker VE; Walker DM Environ Mol Mutagen; 2007; 48(3-4):239-47. PubMed ID: 17358029 [TBL] [Abstract][Full Text] [Related]
15. First-line therapy and mitochondrial damage: different nucleosides, different findings. Blanco F; García-Benayas T; José de la Cruz J; González-Lahoz J; Soriano V HIV Clin Trials; 2003; 4(1):11-9. PubMed ID: 12577192 [TBL] [Abstract][Full Text] [Related]
16. Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age. Divi RL; Leonard SL; Walker BL; Kuo MM; Shockley ME; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC Toxicol Sci; 2007 Sep; 99(1):203-13. PubMed ID: 17545213 [TBL] [Abstract][Full Text] [Related]
17. Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. Van Dyke RB; Wang L; Williams PL; J Infect Dis; 2008 Dec; 198(11):1599-608. PubMed ID: 19000014 [TBL] [Abstract][Full Text] [Related]
18. Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs). Divi RL; Einem TL; Fletcher SL; Shockley ME; Kuo MM; St Claire MC; Cook A; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC Toxicol Sci; 2010 Nov; 118(1):191-201. PubMed ID: 20702595 [TBL] [Abstract][Full Text] [Related]
19. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297 [TBL] [Abstract][Full Text] [Related]
20. Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro. Hoggard PG; Sales SD; Kewn S; Sunderland D; Khoo SH; Hart CA; Back DJ Antivir Chem Chemother; 2000 Nov; 11(6):353-8. PubMed ID: 11227992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]